Erythrocyte-derived optical nano-vesicles as theranostic agents

We have engineered nano-vesicles, derived from erythrocytes, which can be doped with various near infrared (NIR) organic chromophores, including the FDA-approved indocyanine green (ICG). We refer to these vesicles as NIR erythrocyte-mimicking transducers (NETS) since in response to NIR photo-excitation they can generate heat or emit fluorescent light. Using biochemical methods based on reduction amination, we have functionalized the surface of NET with antibodies to target specific biomolecules. We present results that demonstrate the effectiveness of NETs in targeted imaging of cancer cells that over-express the human epidermal growth factor receptor-2 (HER2).

[1]  Seng H. Cheng,et al.  Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice. , 2013, Molecular genetics and metabolism.

[2]  D. Irvine,et al.  Freely Suspended Cellular “Backpacks” Lead to Cell Aggregate Self-Assembly , 2010, Biomacromolecules.

[3]  U Teichgräber,et al.  Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. , 2006, Nano letters.

[4]  Jennifer Sturgis,et al.  A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.

[5]  I. Brandslund,et al.  Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors. , 2008, International journal of oncology.

[6]  Vladimir Tolmachev,et al.  Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  G. Collet,et al.  Trojan horse at cellular level for tumor gene therapies. , 2013, Gene.

[8]  J. M. Lanao,et al.  Cell-based drug-delivery platforms. , 2012, Therapeutic delivery.

[9]  A. Santin,et al.  HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies , 2013, Molecular Diagnosis & Therapy.

[10]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[11]  Vladimir R Muzykantov,et al.  Drug delivery by red blood cells: vascular carriers designed by mother nature , 2010, Expert opinion on drug delivery.

[12]  Antonella Antonelli,et al.  Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. , 2011, Nanomedicine.

[13]  R. Flower,et al.  Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. , 2008, Investigative ophthalmology & visual science.

[14]  Steen J. Madsen,et al.  Macrophages as Cell-Based Delivery Systems for Nanoshells in Photothermal Therapy , 2011, Annals of Biomedical Engineering.

[15]  P. Barthélémy,et al.  Pertuzumab: development beyond breast cancer. , 2014, Anticancer research.

[16]  S. Kaufmann,et al.  Cells as factories for humanized encapsulation. , 2011, Nano letters.

[17]  S. Ritter,et al.  Encapsulation of FITC to monitor extracellular pH: a step towards the development of red blood cells as circulating blood analyte biosensors , 2011, Biomedical optics express.

[18]  M. Magnani,et al.  Cell-based drug delivery. , 2008, Advanced drug delivery reviews.

[19]  Liangfang Zhang,et al.  Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.

[20]  Mark A Milanick,et al.  Engineering erythrocytes to be erythrosensors: first steps. , 2011, Blood cells, molecules & diseases.

[21]  Hon-Man Liu,et al.  Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells , 2010, Nanotechnology.

[22]  Bahman Anvari,et al.  Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications , 2013, Scientific Reports.